Last updated on November 2019

A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Patients With Manifest Huntington's Disease


Brief description of study

This study will evaluate the efficacy, safety, and biomarker effects of RO7234292 (RG6042) compared with placebo in patients with manifest Huntington's disease (HD).

Clinical Study Identifier: NCT03761849

Find a site near you

Start Over

Uab Medicine

Birmingham, AL United States
  Connect »

Stanford Univ Medical Center

Palo Alto, CA United States
  Connect »

SC3 Research Group, Inc

Pasadena, CA United States
  Connect »

Columbia University

New York, NY United States
  Connect »

University of Pittsburgh

Pittsburgh, PA United States
  Connect »

Evergreen Health Care Center

Kirkland, WA United States
  Connect »

Northwestern University

Chicago, IL United States
  Connect »

Dent Neurological Institute

Amherst, NY United States
  Connect »

Queen Elizabeth Hospital

Birmingham, United Kingdom
  Connect »

Royal Hallamshire Hospital

Sheffield, United Kingdom
  Connect »

INEBA

Capital Federal, Argentina
  Connect »

Hospital Britanico de Buenos Aires

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

LUMC

Leiden, Netherlands
  Connect »

Neurozentrum Siloah

Gümligen, Switzerland
  Connect »